GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

New study reveals adding whey protein to dual-source carbohydrates enhances amino acid availability without compromising ...

Overview: Glucagon is commonly used to increase blood sugar levels in people with dangerously low levels. It can also be used during certain tests to slow down gut movement. Common side effects ...

Glucagon can also play a role in how amino acids (compounds that help make up muscles and tissue in your body) make glucose. And it can break down triglycerides, or fat your body stores, into fuel.

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor ...

Insulin and glucagon work together to regulate blood sugar levels and ensure that your body has a constant supply of energy. Insulin and glucagon are hormones that help regulate the levels of ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...